Join us on November 14, 10 AM (EST) for a virtual roundtable discussion featuring top experts from AbbVie, Almac, and the FDA, as they share their insights into the evolving landscape of nitrosamine testing in the pharmaceutical industry.

In this exclusive event, our distinguished panel will address critical topics, including the most significant analytical challenges and how to navigate them, cutting edge technologies, as well as regulatory trends for nitrosamine testing in the pharmaceutical industry.

Key discussion points include:

Overcoming the major challenges in detecting nitrosamines
Current techniques and technologies
How to build a robust method for nitrosamine analysis
The impact of recent regulatory changes on the industry
Future trends in nitrosamine testing and regulatory landscapes

Gain insights from leading voices in pharmaceutical analysis and stay ahead of the latest trends in nitrosamine testing.

Kevin Parker

Senior Scientist I, Analytical R&D, Small Molecule CMC Development, AbbVie

Appearances